Low-dose methotrexate-induced acute interstitial pneumonitis: Report of two cases from South India and review of literature
Methotrexate (MTX) is an antimetabolite used as a disease-modifying agent for various rheumatological conditions. We report two patients who were treated with daily low-dose MTX and developed acute interstitial pneumonitis requiring hospital admission. MTX-induced pneumonitis is a rare life-threaten...
Main Authors: | Ramya Iyyadurai, Ronald Albert Benton Carey, Sowmya Satyendra |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2016-01-01
|
Series: | Journal of Family Medicine and Primary Care |
Subjects: | |
Online Access: | http://www.jfmpc.com/article.asp?issn=2249-4863;year=2016;volume=5;issue=4;spage=875;epage=878;aulast=Iyyadurai |
Similar Items
-
Leflunomide-induced interstitial pneumonitis: A rare occurrence in a case without underlying lung disease
by: V.D. Villgran, et al.
Published: (2021-01-01) -
Methotrexate-induced pneumonitis in Crohn's disease. Case report and review of the literature
by: D'Andrea Nadia, et al.
Published: (2010-10-01) -
Methotrexate-induced Hypersensitivity Pneumonitis appearing after 30 years of use: a case report
by: Mashal Salehi, et al.
Published: (2017-06-01) -
Interstitial pneumonitis caused by everolimus treatment
by: Nilufer Aykac Kongar, et al.
Published: (2016-03-01) -
Paclitaxel induced chronic fibrosing interstitial pneumonitis: a case report and review of the literature
by: Renata Ferrarotto, et al.
Published: (2011-12-01)